<SEC-DOCUMENT>0001558370-20-006307-index.html : 20200511
<SEC-HEADER>0001558370-20-006307.hdr.sgml : 20200511
<ACCEPTANCE-DATETIME>20200511171253
ACCESSION NUMBER:		0001558370-20-006307
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200511
DATE AS OF CHANGE:		20200511
EFFECTIVENESS DATE:		20200511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axsome Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001579428
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				454241907
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238174
		FILM NUMBER:		20865996

	BUSINESS ADDRESS:	
		STREET 1:		200 BROADWAY, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10038
		BUSINESS PHONE:		(212) 332-3241

	MAIL ADDRESS:	
		STREET 1:		200 BROADWAY, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10038
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>axsm-20200508xs8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: axsm-20200508xs8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>axsm-20200508xex5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: axsm-20200508xex5d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>axsm-20200508xex23d2.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: axsm-20200508xex23d2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>axsm-20200508xex99d3.htm
<DESCRIPTION>EX-99.3
<TEXT>
Document 4 - file: axsm-20200508xex99d3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>axsm-20200508xex99d4.htm
<DESCRIPTION>EX-99.4
<TEXT>
Document 5 - file: axsm-20200508xex99d4.htm

</DOCUMENT>
</SEC-DOCUMENT>